Annual Working Capital
$4.45 M
-$7.39 M-62.40%
December 31, 2024
Summary
- As of March 13, 2025, APVO annual working capital is $4.45 million, with the most recent change of -$7.39 million (-62.40%) on December 31, 2024.
- During the last 3 years, APVO annual working capital has fallen by -$13.36 million (-75.01%).
- APVO annual working capital is now -94.19% below its all-time high of $76.57 million, reached on December 31, 2017.
Performance
APVO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.45 M
+$322.00 K+7.80%
December 31, 2024
Summary
- As of March 13, 2025, APVO quarterly working capital is $4.45 million, with the most recent change of +$322.00 thousand (+7.80%) on December 31, 2024.
- Over the past year, APVO quarterly working capital has dropped by -$7.39 million (-62.40%).
- APVO quarterly working capital is now -95.57% below its all-time high of $100.45 million, reached on September 30, 2017.
Performance
APVO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
APVO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.4% | -62.4% |
| 3 y3 years | -75.0% | -62.4% |
| 5 y5 years | +154.0% | -62.4% |
APVO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.3% | at low | -81.8% | +7.8% |
| 5 y | 5-year | -86.4% | +154.0% | -87.2% | +154.0% |
| alltime | all time | -94.2% | +154.0% | -95.6% | +154.0% |
Aptevo Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.45 M(-62.4%) | $4.45 M(+7.8%) |
| Sep 2024 | - | $4.13 M(-0.7%) |
| Jun 2024 | - | $4.16 M(-28.0%) |
| Mar 2024 | - | $5.78 M(-51.2%) |
| Dec 2023 | $11.84 M(-36.8%) | $11.84 M(-17.1%) |
| Sep 2023 | - | $14.29 M(-9.4%) |
| Jun 2023 | - | $15.77 M(-30.5%) |
| Mar 2023 | - | $22.69 M(+21.0%) |
| Dec 2022 | $18.74 M(+5.2%) | $18.74 M(+11.4%) |
| Sep 2022 | - | $16.83 M(-31.0%) |
| Jun 2022 | - | $24.40 M(+36.9%) |
| Mar 2022 | - | $17.82 M(+0.0%) |
| Dec 2021 | $17.81 M(-45.6%) | $17.81 M(-32.8%) |
| Sep 2021 | - | $26.49 M(-24.1%) |
| Jun 2021 | - | $34.90 M(+4.2%) |
| Mar 2021 | - | $33.51 M(+2.4%) |
| Dec 2020 | $32.73 M | $32.73 M(+40.8%) |
| Sep 2020 | - | $23.24 M(+566.6%) |
| Jun 2020 | - | $3.49 M(-55.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $7.83 M(-195.0%) |
| Dec 2019 | -$8.24 M(-126.5%) | -$8.24 M(+1680.6%) |
| Sep 2019 | - | -$463.00 K(-101.7%) |
| Jun 2019 | - | $27.07 M(-31.2%) |
| Mar 2019 | - | $39.35 M(+26.6%) |
| Dec 2018 | $31.08 M(-59.4%) | $31.08 M(-30.9%) |
| Sep 2018 | - | $44.95 M(-6.6%) |
| Jun 2018 | - | $48.15 M(-19.6%) |
| Mar 2018 | - | $59.89 M(-21.8%) |
| Dec 2017 | $76.57 M(+47.6%) | $76.57 M(-23.8%) |
| Sep 2017 | - | $100.45 M(+81.6%) |
| Jun 2017 | - | $55.31 M(-12.1%) |
| Mar 2017 | - | $62.94 M(+21.3%) |
| Dec 2016 | $51.87 M(+241.5%) | $51.87 M(-19.2%) |
| Sep 2016 | - | $64.20 M(+181.3%) |
| Jun 2016 | - | $22.82 M(-50.1%) |
| Mar 2016 | - | $45.72 M(+200.9%) |
| Dec 2015 | $15.19 M(-30.0%) | $15.19 M |
| Dec 2014 | $21.72 M | - |
FAQ
- What is Aptevo Therapeutics annual working capital?
- What is the all time high annual working capital for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual working capital year-on-year change?
- What is Aptevo Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly working capital year-on-year change?
What is Aptevo Therapeutics annual working capital?
The current annual working capital of APVO is $4.45 M
What is the all time high annual working capital for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual working capital is $76.57 M
What is Aptevo Therapeutics annual working capital year-on-year change?
Over the past year, APVO annual working capital has changed by -$7.39 M (-62.40%)
What is Aptevo Therapeutics quarterly working capital?
The current quarterly working capital of APVO is $4.45 M
What is the all time high quarterly working capital for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly working capital is $100.45 M
What is Aptevo Therapeutics quarterly working capital year-on-year change?
Over the past year, APVO quarterly working capital has changed by -$7.39 M (-62.40%)